Results 181 to 190 of about 11,471 (211)

Pharmacogenetics of toxic epidermal necrolysis

Expert Opinion on Pharmacotherapy, 2010
Toxic epidermal necrolysis (TEN) and Stevens-Johnson Syndrome (SJS) are two of the most severe drug-induced cutaneous reactions. Advances in genome technologies have allowed researchers to identify genetic markers associated with this drug-associated event and these have provided a potential tool for prevention.Current updates of genetic biomarkers ...
Ming Ta Michael, Lee, Shuen-Iu, Hung, Chun-Yu, Wei, Yuan-Tsong, Chen   +3 more
openaire   +2 more sources

Intestinal toxic epidermal necrolysis

Gazzetta Medica Italiana Archivio per le Scienze Mediche, 2018
Toxic epidermal necrolysis (TEN), also known as the Stevens-Johnson Syndrome (SJS), is defined as severe, lifethreatening mucocutaneous reactions, predominantly drug induced, but also associated with infectious diseases. Clinical manifestations consist of erythematous cutaneous lesions, with blister formation and epidermal detachment as a consequence ...
Cudia, Antonella, Raggi, Valeria, Dutmann, Ruth, De Bels, David, Devriendt, Jacques   +4 more
openaire   +2 more sources

Management of toxic epidermal necrolysis

Hospital Medicine, 2000
Toxic epidermal necrolysis and Stevens–Johnson syndrome are rare, life-threatening drug reactions. Widespread epidermal necrosis and mucosal erosions lead to complications similar to those developing after extensive burns. Treatment is supportive. The role of steroids and other potential disease-modifying agents remains to be established by controlled ...
openaire   +2 more sources

The management of toxic epidermal necrolysis

Australasian Journal of Dermatology, 2012
ABSTRACTThe mortality rate of Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) is high; approximately 5% for SJS and 25% for TEN. It is therefore vital for the treating physician to recognise SJS and TEN promptly through the identification of these diseases' characteristic clinical features so that the offending drug is promptly ...
openaire   +2 more sources

Biologic TNF-alpha inhibitors in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a systemic review

Journal of Dermatological Treatment, 2020
Shan Zhang, Shunli Tang, Sheng Li
exaly  

Treatment of PD-1 Inhibitor-Associated Toxic Epidermal Necrolysis: A Case Report and Brief Review

OncoTargets and Therapy, 2022
Yidong Zhao, Xiuyu Wang, Tianyi Qian
exaly  

Treating toxic epidermal necrolysis with systemic immunomodulating therapies: A systematic review and network meta-analysis

Journal of the American Academy of Dermatology, 2021
Tsung-Yu Tsai, I-Hsin Huang, Hsiao-Han Wang   +2 more
exaly  

Toxic epidermal necrolysis

ANZ Journal of Surgery, 2010
Nathan M, Harris, Richard B, Wong She
openaire   +2 more sources

Mycoplasma-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: Case-control analysis of a cohort managed in a specialized center

Journal of the American Academy of Dermatology, 2022
Yasmin Chia Chia Liew, Karen Jui Lin Choo, Choon Chiat Oh   +2 more
exaly  

Modified Score of Toxic Epidermal Necrolysis to predict toxic epidermal necrolysis mortality

Journal of the American Academy of Dermatology, 2023
Zahra, Haghani Dogahe, Anahita, Ghorbani, Shahin, Hallaj, Mohammadreza, Mobayen   +3 more
openaire   +2 more sources